VP, Market Access

United Therapeutics•Rtp, NC

10h•Remote

About The Position

The VP, Market Access provides enterprise-level leadership for United Therapeutics' Managed Markets & Reimbursement function, with a dual focus on the company's robust small molecule commercial business and pipeline, as well as its pioneering organ manufacturing (biologic) programs. This role sets the strategic vision for market access and pricing, developing and executing innovative, compliant strategies that ensure optimal patient access, coverage, and reimbursement across all U.S. payer channels (commercial, Medicare/Medicaid, VA/DoD, and emerging value-based care models). The VP is accountable for aligning UT's growth objectives and long-term business goals with evolving market realities, including the Inflation Reduction Act, PBM dynamics, and the rise of specialty and rare disease therapies. The role also supports the launch and commercialization of next-generation organ manufacturing solutions, including xenotransplantation and bioengineered organs, positioning UT as a leader in both pharmaceuticals and regenerative medicine.

Requirements

Bachelor’s Degree
15+ years in pharmaceutical, biotechnology, or related healthcare sectors with a focus on market access, managed markets, and/or reimbursement
8+ years in managed care sales, national accounts, or managed care marketing
8+ years of progressive leadership experience
Extensive experience in managed care strategy, including sales, national accounts, contracting, and payer marketing
Proven track record in developing and executing managed care business plans and integrating strategies with marketing and field sales
Demonstrated success in contract strategy, negotiation, and analysis, as well as executive-level engagement with payer organizations
Leadership experience managing managed care or national accounts teams and influencing cross-functional stakeholders
Deep understanding of payer systems, reimbursement policy, and pricing dynamics, including the unique challenges and opportunities for small molecules and biologics

Nice To Haves

Master’s Degree or additional scientific/clinical credentials
Advanced data and financial modeling, forecasting, and analysis

Responsibilities

Define and lead the overall market access strategy for UT’s small molecule and organ manufacturing portfolios, ensuring optimal coverage, reimbursement, and affordability in alignment with corporate growth objectives and the company’s public benefit mission
Anticipate and respond to evolving payer and policy landscapes, including the impact of the Inflation Reduction Act, 340B program expansion, and the increasing role of PBMs in formulary management and rebate negotiations
Develop and execute pre-launch and launch market access strategies for new small molecule and biologic products, including organ manufacturing innovations, leveraging real-world evidence, value-based contracting, and patient-centric approaches
Establish frameworks for pricing, contracting, and payer engagement that maximize access and net revenue performance, with a focus on gross-to-net optimization and mitigation of GTN erosion
Oversee government pricing compliance and contracting strategies to mitigate risk and maintain regulatory integrity, especially as new biologic and organ manufacturing therapies enter the market
Ensure governance and compliance across all market access activities, including adherence to evolving fair market value standards for enhanced pharmacy and patient support services
Partner with Commercial, Finance, Health Economics & Outcomes Research, Policy, and R&D teams to integrate market access considerations into brand planning, lifecycle management, and pipeline prioritization
Provide strategic guidance on payer messaging, value propositions, and evidence generation to support negotiations, formulary positioning, and innovative access models (e.g., direct-to-patient, digital health integration)
Engage externally with industry associations, policy forums, and payer organizations to influence market access trends, advocate for patient access, and shape the regulatory environment for both small molecules and organ manufacturing solutions
Monitor market trends, policy changes, and competitive dynamics—including biosimilar and generic competition, patent cliffs, and the rise of specialty pharmacy—to identify opportunities and risks impacting access and pricing
Maintain executive-level communication on market access performance, emerging opportunities, and strategic priorities, ensuring leadership is informed of significant developments and implications
Manage departmental budget and resource allocation to ensure operational efficiency and strategic impact
Direct and manage direct reports, including responsibilities for training, goal setting, performance management, coaching, mentoring, and career development, supporting recruitment and retention of top market access talent